ARS Pharmaceuticals, Inc. (SPRY) quarterly cash flow statement — complete operating, investing & financing history
ARS Pharmaceuticals, Inc. (SPRY) cash flow statement — 8-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -60.93M | -44.95M | -43.48M | -47.05M | -39.59M | -40.74M | 42M | -14.47M | -7.28M | -6.71M | -17.41M | -12.76M | -16.67M | -12.43M | -20.5M | -5.68M | -6.97M | -6.92M | -21.3M | -19.12M |
| Operating CF Margin % | -181.02% | -198.17% | -154.82% | -144.76% | -251.91% | -511% | 48.51% | -699.56% | -1455.8% | - | - | - | -166690% | -62145% | - | -3006.35% | -1503.02% | -1044.49% | -2825.6% | -3621.02% |
| Operating CF Growth % | -53.89% | -10.32% | -203.53% | -225.2% | -443.92% | -507.18% | 341.33% | -13.35% | 56.33% | 46.01% | 15.09% | -124.62% | -139.02% | -79.48% | 3.79% | 70.28% | 50.66% | 43.24% | - | - |
| Net Income | -62.34M | -60.62M | -41.32M | -51.15M | -44.88M | -33.94M | 49.93M | -19.13M | -12.52M | -10.29M | -7.17M | -14.87M | -17.37M | -14.96M | -14.43M | -6.58M | -6.42M | -7.25M | -23.46M | -22.66M |
| Depreciation & Amortization | 416K | 397K | -1.54M | 2.35M | 279K | -1.68M | -1.51M | 21K | 18K | 11K | 12K | 21K | 20K | -1.79M | 14K | 7K | 488K | 50K | 430K | 541K |
| Stock-Based Compensation | 12.39M | 7.42M | 5.74M | 5.69M | 5.37M | 5.3M | 4.26M | 3.59M | 3.37M | 3.31M | 2.28M | 2.61M | 0 | 2.25M | 4.76M | 460K | 0 | 264K | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -11.18M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.44M | -745K | 1.11M | -2.87M | 693K | 0 | 0 | 2.51M | -1.9M | -1.98M | 9.43M | -1.56M | 346K | 0 | -10.06M | 710K | -86K | -1K | 5.15M | 5.02M |
| Working Capital Changes | -12.84M | 8.6M | -7.46M | -1.07M | -1.05M | -10.42M | -10.68M | -1.46M | 3.76M | 2.24M | -10.77M | 1.03M | 335K | 2.07M | -781K | -276K | -956K | 12K | -3.43M | -2.02M |
| Change in Receivables | -20.63M | -839K | 11.18M | -14.01M | -13.25M | -1.13M | -7.4M | -773K | 0 | 0 | 0 | 0 | 0 | 0 | 328K | -328K | 0 | 0 | 0 | 0 |
| Change in Inventory | 13K | -294K | -9.72M | 963K | -4.78M | -8.45M | -5.76M | -183K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 10.52M | 10.31M | -9.06M | 10.96M | 12.81M | 4.17M | 12.02M | 0 | 3.07M | 1.34M | -8.88M | 1.12M | 224K | 0 | 0 | 0 | -267K | 0 | -388K | -367K |
| Cash from Investing | 41.57M | 27.79M | 24.11M | -44.98M | 48.57M | 29.06M | -101.76M | 16.82M | -12.65M | -8.51M | 26.04M | -46.64M | 44.97M | -111.55M | -126K | -30K | -22K | -21K | -25.68M | -40.06M |
| Capital Expenditures | 0 | 0 | 0 | -197K | -51K | -91K | -302K | -140K | -38K | -83K | 91K | -43K | -30K | -193K | -126K | -30K | -22K | -21K | -550K | -87K |
| CapEx % of Revenue | - | - | - | 0.61% | 0.32% | 1.14% | 0.35% | 6.77% | 7.6% | - | - | - | 300% | 965% | - | 15.87% | 4.74% | 3.17% | 72.94% | 16.48% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -25.95M | 46.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | -2M | -5.86M | 0 | 0 | -5M | -2.5M | 0 | 0 | 25.95M | -46.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 3.2M | 159K | 1.13M | 100.05M | 2.7M | 725K | 70.92M | 680K | 545K | 258K | 1.8M | 921K | 2.85M | 1.32M | 193.82M | -1.56M | -623K | -908K | 275K | 148K |
| Debt Issued (Net) | 0 | 0 | -732K | 96.99M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.95M | -909K | -910K | -908K | 0 | 0 |
| Equity Issued (Net) | 786K | 62K | 1.78M | 479K | 2.7M | 725K | 1.53M | 680K | 545K | 258K | 1.8M | 921K | 2.85M | 0 | 0 | 0 | 287K | 0 | 275K | 148K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 2.41M | 97K | 83K | 2.58M | 0 | 0 | 69.38M | 0 | 0 | 0 | 0 | 0 | 0 | 1.32M | 199.77M | -647K | 0 | 0 | 0 | 0 |
| Net Change in Cash | -16.16M | -17M | -18.24M | 8.02M | 11.68M | -10.95M | 11.16M | 3.03M | -19.38M | -14.96M | 10.44M | -58.48M | 31.16M | -122.66M | 173.2M | -7.27M | -15.3M | -7.85M | -46.62M | -59.03M |
| Free Cash Flow | -60.93M | -44.95M | -43.48M | -47.24M | -39.64M | -40.83M | 41.7M | -14.61M | -7.32M | -6.79M | -17.31M | -12.81M | -16.7M | -12.62M | -20.62M | -5.71M | -7M | -6.95M | -21.86M | -19.21M |
| FCF Margin % | -181.02% | -198.17% | -154.82% | -145.36% | -252.23% | -512.14% | 48.17% | -706.33% | -1463.4% | - | - | - | -166990% | -63110% | - | -3022.22% | -1507.76% | -1047.66% | -2898.54% | -3637.5% |
| FCF Growth % | -53.69% | -10.07% | -204.28% | -223.43% | -441.79% | -501.1% | 340.86% | -14.06% | 56.18% | 46.18% | 16.05% | -124.19% | -138.69% | -81.72% | 5.64% | 70.26% | 52.84% | 43.23% | - | - |
| FCF per Share | -0.61 | -0.45 | -0.44 | -0.48 | -0.40 | -0.42 | 0.43 | -0.15 | -0.08 | -0.07 | -0.18 | -0.13 | -0.18 | -0.13 | -0.22 | -0.06 | -0.07 | -0.07 | -0.62 | -0.55 |
| FCF Conversion (FCF/Net Income) | 0.98x | 0.74x | 1.05x | 0.92x | 0.88x | 1.20x | 0.84x | 0.76x | 0.58x | 0.65x | 2.43x | 0.86x | 0.96x | 0.83x | 1.42x | 0.86x | 1.09x | 0.96x | 4.14x | 3.29x |
| Interest Paid | 2.33M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 366K | 0 | 0 | 114K | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |